Nektar Therapeutics Basic Shares Outstanding (Weighted Average)
Nektar Therapeutics (NKTR) reported Basic Shares Outstanding (Weighted Average) of 33.05 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Nektar Therapeutics weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 33.05M shares, a 134.64% increase year-over-year.
- Nektar Therapeutics weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 24.74M shares, a 75.89% increase year-over-year.
- Nektar Therapeutics weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 20.33M shares, a 45.40% increase year-over-year.
- Nektar Therapeutics weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 18.95M shares, a 35.82% increase year-over-year.
- Nektar Therapeutics weighted average number of shares outstanding, basic for fiscal 2025 was 16.87M shares, a 23.05% increase from fiscal 2024.
- Nektar Therapeutics weighted average number of shares outstanding, basic for fiscal 2024 was 13.71M shares, a 92.78% decline from fiscal 2023.
- Nektar Therapeutics weighted average number of shares outstanding, basic for fiscal 2023 was 190.00M shares, a 1.53% increase from fiscal 2022.
- Nektar Therapeutics weighted average number of shares outstanding, basic for fiscal 2022 was 187.14M shares, a 2.09% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 33.05M shares 10-Q · filed 2026-08-14 | 28.92M shares 10-Q · filed 2026-08-14 | 26.04M shares derived: average of 3 quarters · filed 2026-08-14 | 24.27M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 24.74M shares 10-Q · filed 2026-05-08 | 22.54M shares derived: average of 2 quarters · filed 2026-05-08 | 21.34M shares derived: average of 3 quarters · filed 2026-05-08 | 19.53M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 20.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 19.64M shares derived: average of 2 quarters · filed 2026-03-13 | 17.79M shares derived: average of 3 quarters · filed 2026-08-14 | 16.87M shares 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | 18.95M shares 10-Q · filed 2025-11-07 | 16.52M shares derived: average of 2 quarters · filed 2026-08-14 | 15.72M shares 10-Q · filed 2025-11-07 | 15.27M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 14.09M shares 10-Q · filed 2026-08-14 | 14.07M shares 10-Q · filed 2026-08-14 | 14.05M shares derived: average of 3 quarters · filed 2026-08-14 | 14.02M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 14.06M shares 10-Q · filed 2026-05-08 | 210.92M shares 10-Q · filed 2025-05-09 | 14.02M shares derived: average of 2 quarters · filed 2026-05-08 | 14.00M shares derived: average of 3 quarters · filed 2026-05-08 | 13.98M shares derived: average of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | 13.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 13.97M shares derived: average of 2 quarters · filed 2026-03-13 | 13.95M shares derived: average of 3 quarters · filed 2026-03-13 | 13.71M shares 10-K · filed 2026-03-13 | 205.66M shares 10-K · filed 2025-03-14 | |||
| 2024-09-30 | 13.95M shares 10-Q · filed 2025-11-07 | 209.25M shares 10-Q · filed 2024-11-08 | 13.94M shares derived: average of 2 quarters · filed 2025-11-07 | 13.62M shares 10-Q · filed 2025-11-07 | 204.29M shares 10-Q · filed 2024-11-08 | 103.42M shares derived: average of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | 13.92M shares 10-Q · filed 2025-08-08 | 208.83M shares 10-Q · filed 2024-08-09 | 13.45M shares 10-Q · filed 2025-08-08 | 201.79M shares 10-Q · filed 2024-08-09 | 133.24M shares derived: average of 3 quarters · filed 2025-08-08 | 147.53M shares derived: average of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | 194.75M shares 10-Q · filed 2025-05-09 | 192.90M shares derived: average of 2 quarters · filed 2025-05-09 | 192.07M shares derived: average of 3 quarters · filed 2025-05-09 | 191.46M shares derived: average of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | 191.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 190.73M shares derived: average of 2 quarters · filed 2025-03-14 | 190.37M shares derived: average of 3 quarters · filed 2025-03-14 | 190.00M shares 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | 190.41M shares 10-Q · filed 2024-11-08 | 190.03M shares derived: average of 2 quarters · filed 2024-11-08 | 189.65M shares 10-Q · filed 2024-11-08 | 189.30M shares derived: average of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | 189.66M shares 10-Q · filed 2024-08-09 | 189.27M shares 10-Q · filed 2024-08-09 | 188.93M shares derived: average of 3 quarters · filed 2024-08-09 | 188.61M shares derived: average of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | 188.88M shares 10-Q · filed 2024-05-10 | 188.56M shares derived: average of 2 quarters · filed 2024-05-10 | 188.26M shares derived: average of 3 quarters · filed 2024-05-10 | 187.89M shares derived: average of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | 188.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 187.95M shares derived: average of 2 quarters · filed 2024-03-05 | 187.56M shares derived: average of 3 quarters · filed 2024-03-05 | 187.14M shares 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | 187.64M shares 10-Q · filed 2023-11-08 | 187.22M shares derived: average of 2 quarters · filed 2023-11-08 | 186.77M shares 10-Q · filed 2023-11-08 | 186.32M shares derived: average of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | 186.80M shares 10-Q · filed 2023-08-09 | 186.32M shares 10-Q · filed 2023-08-09 | 185.88M shares derived: average of 3 quarters · filed 2024-03-05 | 185.44M shares derived: average of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | 185.85M shares 10-Q · filed 2023-05-10 | 185.42M shares derived: average of 2 quarters · filed 2024-03-05 | 184.98M shares derived: average of 3 quarters · filed 2024-03-05 | 184.41M shares derived: average of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | 184.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 184.55M shares derived: average of 2 quarters · filed 2024-03-05 | 183.93M shares derived: average of 3 quarters · filed 2024-03-05 | 183.30M shares 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | 184.11M shares 10-Q · filed 2022-11-04 | 183.40M shares derived: average of 2 quarters · filed 2022-11-04 | 182.74M shares 10-Q · filed 2022-11-04 | 181.97M shares derived: average of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | 182.70M shares 10-Q · filed 2022-08-05 | 182.04M shares 10-Q · filed 2022-08-05 | 181.26M shares derived: average of 3 quarters · filed 2023-02-28 | 180.72M shares derived: average of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | 181.37M shares 10-Q · filed 2022-05-06 | 180.54M shares derived: average of 2 quarters · filed 2023-02-28 | 180.06M shares derived: average of 3 quarters · filed 2023-02-28 | 179.63M shares derived: average of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | 179.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 179.40M shares derived: average of 2 quarters · filed 2023-02-28 | 179.04M shares derived: average of 3 quarters · filed 2023-02-28 | 178.58M shares 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | 179.09M shares 10-Q · filed 2021-11-05 | 178.71M shares derived: average of 2 quarters · filed 2021-11-05 | 178.20M shares 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | 178.33M shares 10-Q · filed 2021-08-06 | 177.75M shares 10-Q · filed 2021-08-06 | ||||||
| 2019-12-31 | 176.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 175.77M shares derived: average of 2 quarters · filed 2022-03-01 | 175.37M shares derived: average of 3 quarters · filed 2022-03-01 | 174.99M shares 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | 175.40M shares 10-Q · filed 2019-11-07 | 174.98M shares derived: average of 2 quarters · filed 2019-11-07 | 174.61M shares 10-Q · filed 2019-11-07 | |||||
| 2019-06-30 | 174.55M shares 10-Q · filed 2019-08-09 | 174.21M shares 10-Q · filed 2019-08-09 | ||||||
| 2018-12-31 | 173.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 173.00M shares derived: average of 2 quarters · filed 2021-02-26 | 172.46M shares derived: average of 3 quarters · filed 2021-02-26 | 169.60M shares 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | 172.70M shares 10-Q · filed 2019-11-07 | 172.04M shares derived: average of 2 quarters · filed 2019-11-07 | 168.36M shares 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | 171.38M shares 10-Q · filed 2019-08-09 | 166.16M shares 10-Q · filed 2019-08-09 | ||||||
| 2017-12-31 | 158.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 157.38M shares derived: average of 2 quarters · filed 2020-02-28 | 156.71M shares derived: average of 3 quarters · filed 2020-02-28 | 155.95M shares 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | 156.41M shares 10-Q · filed 2018-11-08 | 155.88M shares derived: average of 2 quarters · filed 2018-11-08 | 155.15M shares 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | 155.35M shares 10-Q · filed 2018-08-09 | 154.51M shares 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | 149.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 143.12M shares derived: average of 2 quarters · filed 2019-03-01 | 139.60M shares 10-K · filed 2019-03-01 | |||||
| 2016-09-30 | 137.09M shares 10-Q · filed 2017-11-08 | 136.41M shares 10-Q · filed 2017-11-08 | ||||||
| 2016-03-31 | 135.79M shares 10-Q · filed 2016-05-04 | |||||||
| 2015-09-30 | 132.63M shares 10-Q · filed 2015-11-06 | 131.88M shares 10-Q · filed 2015-11-06 | ||||||
| 2015-03-31 | 131.36M shares 10-Q · filed 2016-05-04 | |||||||
| 2014-09-30 | 127.50M shares 10-Q · filed 2015-11-06 | 126.04M shares 10-Q · filed 2015-11-06 | ||||||
| 2014-03-31 | 123.54M shares 10-Q · filed 2015-05-01 | |||||||
| 2013-09-30 | 115.81M shares 10-Q · filed 2014-11-07 | 115.56M shares 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |